logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Juan Miguel Cejalvo

hospital clinico universitario de valencia
H指数:26
被引数:3,381

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Radioguided Surgery and Axillary Management in Breast Cancer: From Molecular Imaging to 3D Navigation Toward Personalized Treatment

乳腺癌的放射性引导手术与腋窝管理：从分子成像到3D导航走向个体化治疗

Life
IF3.4
2026-07-090
OA
John Orozco Cortés; Marta Tapia; Jorge Sabater Sancho; Carolina Castillo Arias; Elvira Buch Villa; Ernesto Muñoz Sornosa; Vicente Lopez Flor; Rafael Diaz Exposito; Luisa Fernanda Leon; Catalina Sampol Bas; David Carrera Salazar; Begoña Bermejo; Sergi Vidal Sicart; Juan Miguel Cejalvo Andujar
Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE Project

对接受曲妥珠单抗-德鲁替卡治疗晚期乳腺癌患者UGT1A1胚系变异的分析：PROCURE项目结果

ESMO Open
IF8.3
2026-05-110
OAAI
R. Sánchez-Bayona; J. de Nicolás-Hernández; C. Saura; M. Gion; J.M. Cejalvo; E. Llabrés; J. Cortés; A. Falcón; S. Pernas; A. López de Sa; M. Vidal; C. Hinojo; T. Curiel; J. Cruz; V. Martínez; B. Cantos; M.J. Echarri; I. Gallegos; C. Bueno; A.M. Vargas
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial

PD1疗法在PD1高表达mRNA肿瘤中的疗效：SOLTI-1904 ACROPOLI II期试验中队列1和队列2的结果

ESMO Open
IF8.3
2025-09-300
OAAI
E. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero
Enhancing precision oncology: the role of molecular tumor boards in early identification and targeted treatment of ESCAT II-III alterations

增强精准肿瘤学：分子肿瘤委员会在早期识别和靶向治疗ESCAT II-III改变中的作用

ESMO Open
IF8.3
2025-09-240
PREAI
V. Seguí; J.A. Carbonell-Asins; J. Martín-Arana; M. García-Bartolomé; N. Grimalt; C. Martinez-Ciarpaglini; J.F. Gonzalez-Muñoz; P. Martín-Martorell; I. Gonzalez-Barrallo; A. Viala; M. Tapia; M. Huerta; G. Bruixola; A. Insa; J.M. Cejalvo; T. Fleitas; N. Tarazona; A. Cervantes; D. Roda; V. Gambardella
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study

Zanidatamab联合palbociclib和fulvestrant治疗既往接受过治疗的激素受体阳性、HER2阳性转移性乳腺癌：一项两阶段、多中心、单臂、2a期研究的主要结果

lancet oncology
IF0
2025-05-050
PRE
Santiago Escrivá-de-Romani; Juan M Cejalvo; Emilio Alba; Jennifer Friedmann; Álvaro Rodríguez-Lescure; Marie-France Savard; Rossanna C Pezo; Maria Gion; Manuel Ruiz-Borrego; Erika Hamilton; Timothy Pluard; Marc Webster; Muralidhar Beeram; Hannah Linden; Cristina Saura; Diana Shpektor; Bob Salim; Phoebe Harvey; Sara A Hurvitz
Correlation of the HER2DX Genomic Test withPathologic Features in Early-Stage HER2+BreastCancer
LABORATORY INVESTIGATION
IF4.2
2025-03-010
PRE
Sanfeliu, Esther; Martinez-Romero, Anabel; Marin-Aguilera, Mercedes; Gonzalez-Farre, Blanca; Galvan, Patricia; Infantes, Angela Aguirre; Alarcon, Valeria Sirenko; Blasco, Paula; Castillo, Oleguer; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butille, Joan Anton; Martinez, Antonio; Munoz, Montserrat; Losada, MariaVidal; Pascual, Tomas; Martinez, Olga; Solis, Elia Segui; Garcia-Fructuoso, Isabel; Cejalvo, Juan Miguel; Ciruelos, Eva; Brunet, Laia Pare; Vivancos, Ana; Villagrasa, Patricia; Buckingham, Wesley; Parker, Joel; Braso-Maristany, Fara; Prat, Aleix
Prevalence of HER2-low breast cancer in the GEICAM/2011-06 trial: Agreement in HER2-low classification between standardized immunohistochemistry assays

GEICAM/2011-06试验中HER2-low乳腺癌的患病率：标准化免疫组化检测在HER2-low分类上的一致性

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Rojo, F.; Calvo-Martinez, L.; Bermejo, B.; Bernet, L.; Burgues, O.; Garcia-Caballero, T.; Lopez-Tarruella Cobo, S.; Perez, S.; Antolin-Novoa, S.; Cejalvo, J. M.; Jerez Gilarranz, Y.; Morales Estevez, C.; Reboredo Rendo, C.; Martinez, M. T. M.; Herranz, J.; Rincon Sanchez, R.; Caballero, R.; Barnadas, A.; De la Haba Rodriguez, J.; Martin Jimenez, M.
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
NATURE COMMUNICATIONS
IF15.7
2024-07-111
OAAI
Braso-Maristany, Fara; Ferrero-Cafiero, Juan Manuel; Falato, Claudette; Martinez-Saez, Olga; Cejalvo, Juan Miguel; Margeli, Mireia; Tolosa, Pablo; Salvador-Bofill, Francisco Javier; Cruz, Josefina; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Odena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana Maria; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sanchez-Bayona, Rodrigo; Ciruelos, Eva; Espinosa-Bravo, Martin; Izarzugaza, Yann; Galvan, Patricia; Matito, Judith; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-Dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomas; Prat, Aleix; Oliveira, Mafalda
Primary results from a phase 2a study of zanidatamab (zani) plus palbociclib (palbo) plus fulvestrant (fulv) in HER2+/HR+ metastatic breast cancer (mBC)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Escriva-de-Romani, Santiago; Cejalvo, Juan Miguel; Alba, Emilio; Friedmann, Jennifer; Lescure, Alvaro Rodriguez; Savard, Marie-France; Pezo, Rossanna C.; Gion, Maria; -Borrego, Manuel Ruiz; Hamilton, Erika; Pluard, Timothy; Webster, Marc; Beeram, Muralidhar; Linden, Hannah; Saura, Cristina; Shpektor, Diana; Salim, Bob; Harvey, Phoebe; Hurvitz, Sara
Enhancing Informative Outcomes with Liquid Biopsy in a Real-World Population of Patients with Advanced Breast Cancer: Analysis of the SOLTI-1903 HOPE Study
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Pascual, Tomas; Segui, Elia; Olivera-Salguero, Ruben; Cejalvo, Juan Miguel; Oliveira, Mafalda; Tolosa, Pablo; Vidal, Maria; Malumbres, Marcos; Gavila, Joaquin; Saura, Cristina; Pernas, Sonia; Lopez, Rafael; Margeli, Mireia; Balmana, Judith; Munoz, Montserrat; Blancas, Isabel; Boni, Valentina; Ciruelos, Eva; Galve, Elena; Perello, Antonia; Sanchez-Bayona, Rodrigo; De La Cruz, Susana; De La Hoya, Miguel; Blanch-Torras, Aura; Sposito, Rosana; Canes, Jordi; Masanas, Helena; Olmos, Rosa; Forns, Margarita; Prieto, Maria Jose; Casas, Ana; Prat, Aleix
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
2024-01-035
OAAI
Santana-Hernandez, Sara; Suarez-Olmos, Jesus; Servitja, Sonia; Berenguer-Molins, Pau; Costa-Garcia, Marcel; Comerma, Laura; Rea, Anna; Perera-Bel, Julia; Menendez, Silvia; Arpi, Oriol; Bermejo, Begona; Martinez, Maria Teresa; Cejalvo, Juan Miguel; Comino-Mendez, Inaki; Pascual, Javier; Alba, Emilio; Lopez-Botet, Miguel; Rojo, Federico; Rovira, Ana; Albanell, Joan; Muntasell, Aura
Efficacy of spartalizumab across multiple cancer types in patients with PD1-high mRNA expressing tumors (SOLTI1904 ACROPOLI)

spartalizumab在表达PD1-high mRNA的肿瘤患者中跨多种癌症类型的疗效 (SOLTI1904 ACROPOLI)

ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Prat, A.; Pascual, T.; Juan, M.; Paz-Ares, L.; Felip, E.; Garralda, E.; Gonzalez-farre, B.; Fernandez, A. M. Arance; Martin-Liberal, J.; Lopez, A.; Peron, Y. Izarzugaza; Garcia-Corbacho, J.; Manich, C. Saura; Hierro, C.; Torres, E. Sanfeliu; Cejalvo, J. M.; Salvador, F.; Nin, R. Mesia; Cervantes, A.; Tabernero, J.
First results of the SOLTI-1903 HOPE's patient-centric molecular screening program in advanced breast cancer

SOLTI-1903希望以患者为中心的晚期乳腺癌分子筛查计划的第一个结果

ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OAAI
Pascual, T.; Segui Solis, E.; Olivera-Salguero, R.; Cejalvo, J. M.; Oliveira, M.; Tolosa Ortega, P.; Vidal Losada, M. J.; Malumbres, M.; Gavila-Gregori, J.; Saura Manich, C.; Pernas Simon, S.; Margeli Vila, M.; Ciruelos, E. M.; Galve-Calvo, E.; Galvan, P.; Sanfeliu Torres, E.; Olmos, R.; Forns, M.; Fernandez Tejerina, A. Casas; Prat, A.

研究方向

暂未获取到该数据
A
Aleix Prat
H 指数:92论文数:1,351被引数:3.6万
T
Tomás Pascual
H 指数:35论文数:449被引数:5,518
A
Andrés Cervantes
H 指数:99论文数:1,158被引数:6.1万
B
Begoña Bermejo
H 指数:41论文数:635被引数:6,645
A
Aňa Lluch
H 指数:72论文数:794被引数:2.6万
M
María Vidal
H 指数:43论文数:425被引数:1.1万
B
Blanca González‐Farré
H 指数:34论文数:200被引数:5,266
M
Mafalda Oliveira
H 指数:48论文数:564被引数:1.3万
C
Cristina Saura
H 指数:61论文数:740被引数:1.8万
E
Esther Sanfeliu
H 指数:19论文数:131被引数:2,739